Podcasts360
Podcasts360
Consultant360
George Karpouzas, MD, on β-2 Glycoprotein 1 IgA Antibodies and Coronary Outcomes in RA
11 minutes Posted Apr 14, 2020 at 7:40 pm.
0:00
11:07
Download MP3
Show notes
In this podcast, George Karpouzas, MD, discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients with rheumatoid arthritis. More at: www.consultan360.com/rheumatology